APA (7th ed.) Citation

Yu, A., Chen, Y., Tsai, C., Wu, Y. A., Su, M., Chou, C., . . . Lin, Y. (2024). Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy. Journal of the American Heart Association, 13(2), e030512. https://doi.org/10.1161/JAHA.123.030512

Chicago Style (17th ed.) Citation

Yu, An‐Li, et al. "Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy." Journal of the American Heart Association 13, no. 2 (2024): e030512. https://doi.org/10.1161/JAHA.123.030512.

MLA (9th ed.) Citation

Yu, An‐Li, et al. "Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy." Journal of the American Heart Association, vol. 13, no. 2, 2024, p. e030512, https://doi.org/10.1161/JAHA.123.030512.